pulmonary delivery
new technology
Delivery of PULmonary Therapeutics
therapeutic delivery of medicines
TARgetted Delivery
effective delivery
clinical gene therapies
new therapies
lungs
new ultrasonic technology
different medicines
proprietary technology
gene therapy
clinical outcomes
pulmonary arterial hypertension
chronic obstructive pulmonary disease
inhalation of medicines
cystic fibrosis patients
precise nebulisation technology
people
work
strand
forms of lung disease
efficacy of treatment
appealing treatment
aerosol droplets
overall aim
selective targeting of different tissue types
therapeutic system transits
aerosol droplet sizes
genes
RNA
industry
substantial anatomical barriers
routes
specific regions
impact
enhanced drug uptake
epithelium
quality of data
biologics
Phononics
vascular cells
respiratory diseases
innovation
example
commercial team
limitations
healthcare costs
prototype nebuliser
asthma
aerosols
accepted wisdom
loss
market
deaths
model mouse
DALYS
year
Î¼m